Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

NCT05293509 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped 0 accrual

Conditions

Stem Cell Transplantation

Interventions

DRUG: Fludarabine
DRUG: Dexamethasone
DRUG: Cyclophosphamide
DRUG: Bortezomib
DRUG: Rituximab
DRUG: Busulfan
DRUG: Cyclophosphamide (Cy)
DRUG: Tacrolimus (or cyclosporine)
DRUG: Mycophenolate mofetil (MMF)
DRUG: Rabbit ATG

Sponsor

M.D. Anderson Cancer Center